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PEPTIDE MEDIATED INHIBITION OF P. GINGIVALIS DUAL AND THREE 
SPECIES BIOFILMS  
NAGA SRINIJA GUMMADI 
November 27, 2013 
 
The colonization of Porphyromonas gingivalis is the key phase in transformation of 
bacterial biofilm from a commensal plaque to pathogenic form observed in periodontitis. 
Objectives: The goals of this study are to establish optimum levels of Porphyromonas 
gingivalis, Streptococcus gordonii and Fusobacterium nucleatum to reproducibly generate 
dual and three species biofilms and examine inhibition of biofilm formation by BAR 
peptide and BAR analogs C1-24 R1182 I1185 BAR, R1182 I1185 BAR and C1-24 BAR. Methods: 
S. gordonii was grown in BHIY media; P. gingivalis and F. nucleatum were grown in 
TSBY and BHI media respectively supplemented with hemin and menadione. Labeled S. 
gordonii was adhered to a cover glass in wells of a culture plate for 18-24 hours and then 
labeled P. gingivalis or P. gingivalis and F. nucleatum were added. After incubating for 
18-24 hours, the cover glass is fixed, mounted onto a slide glass and visualized by confocal 
laser scanning microscopy. Biofilm images were assembled and analyzed using Volocity 
software. Results: For establishing the optimum inocula for Streptococcus gordonii, 
Porphyromonas gingivalis and Fusobacterium nucleatum- biofilms were formed using 
cultures of optical densities 0.05, 0.1, 0.2, 0.5, 0.8, 1.0 and 2.0. Optimal conditions were 
found to use S. gordonii at O.D 0.8, P. gingivalis at O.D 0.1(for 2 species), 0.2(for 3species) 
and Fusobacterium nucleatum at O.D 2.0. After the conditions were established, P. 
gingivalis was incubated with BAR peptide or BAR peptide analogs (0 –50µg/ml) prior to 
addition to S. gordonii to assess inhibition of biofilm formation. BAR peptide and peptide 
analogs significantly inhibited the biofilms. Inhibition of dual species biofilms by R1182 
I1185BAR is statistically greater (P <0.001) compared to parent BAR. Conclusion: Ideal 
conditions for biofilms were established. BAR peptide and peptide analogs significantly 
inhibited adherence of P. gingivalis in both dual and three species complex biofilms  
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CHAPTER – 1 
INTRODUCTION 
          Periodontal disease is one of the most common oral disease among adults worldwide 
and remains as a major oral health care burden globally.  Periodontal disease when left 
untreated can lead to chronic inflammation causing alveolar bone resorption and 
subsequent loss of teeth.  According to the American Academy of Periodontology, 
periodontal disease is a chronic inflammatory disease that affects the gum tissue and bone 
supporting the teeth and data from the Centers for Disease Control and Prevention show 
high prevalence of periodontal disease in the U.S. population1.  According to this study 
50% of the American adult population at an age 30 and above exhibit some form of 
periodontitis1.  
          It’s estimated that 47.2 percent of American adult population – nearly 64.7 million 
have mild, medium or severe periodontitis1.  Severe periodontitis, which may result in tooth 
loss, is found in 5–20% of most adult populations worldwide2, 3.  A study conducted by the 
Center for Disease Control and Prevention(CDC) demonstrated a high burden of 
periodontal disease in the adult United States population especially among age group 65 
and older1.  
       Previous research studies have suggested that oral health might be indicative of overall 
general health4.  These studies have also shown that periodontal disease was found to be
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 associated with systemic conditions such as coronary artery disease, stroke, type 2 diabetes 
mellitus, severe osteopenia, pre-term or low birth weight babies and respiratory infections8, 
4.  
          A frequent occurrence in chronic periodontitis is sub-gingival calculus5.  An 
international workshop conducted in 1999 categorized a general guide for severity on the 
basis of clinical loss of attachment (CAL) as follows: slight or mild = 1-2mm CAL; 
moderate= 3-4 mm CAL; severe= 5mm CAL 6.  
          United States annual expenditure on periodontal and preventive periodontal 
procedures was $14.3 billion in 1999 7.   
 
Significance of Dental Plaque in Oral health and disease: 
          The human oral cavity is similar to any other habitat present in the human body in 
hosting a variety of microflora.  Among the microflora present in the oral cavity, bacteria 
are the most numerous and diverse group 8 and are the primary etiologic agents in 
periodontal disease 9.  
          Bacteria may be present either in free floating form or as being adhered to a surface 
9. Bacterial attachment to a surface activates an entirely different set of genes in the 
bacterium resulting in imparting different characteristics to the bacterium which differ from 
those that it had as a free-floating organism 9.  
          Previous research studies have shown that most of the bacteria exist in the form of 
biofilms which are characterized by highly organized densely populated bacterial 
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communities embedded in an extracellular polymeric matrix 9, 10.  A biofilm is mainly 
constituted by bacterial microcolonies, an extra cellular slime layer, fluid channels and a 
primitive communication system 9.  Each bacterial microcolony is a small independent 
group of bacteria comprising thousands of compatible bacteria 9.  During the biofilm 
formation the bacteria adhere to the surface and to each other thus forming clusters 
resulting in mushroom shaped bacterial micro colonies surrounded by an extracellular 
slime layer 9.  These mushroom shaped bacterial microcolonies are characterized by a 
narrow base that facilitates in there attachment to the surface 9.   
          Each biofilm is distinct in composition with diverse combinations of a wide variety 
of oral bacteria present9.  These diverse group of bacteria have different physiological 
needs and require different living conditions for their survival9.  The biofilm structure is 
well organized that it serves the diverse needs of different bacterial microflora9.  The 
bacteria present in the core of the bacterial microcolony survive under strict anaerobic 
environment while aerobic bacteria survive at the edges of fluid channels where aerobic 
environment prevails9.  The extracellular slime layer provides protection to the bacterial 
microcolonies against antibiotics, antimicrobials, chemotherapeutic agents and host 
defense mechanisms9.  A primitive communication system exists between the bacterial 
micro colonies in which they communicate with each other through chemical signals9.  The 
fluid channels pass through the slimy extracellular matrix and provide nutrition and oxygen 
to the bacterial microcolonies9.  In addition they also facilitate the movement of enzymes 




The bacteria present in the biofilms adhere to tooth surfaces, restorations, dental prosthetic 
appliances and on oral mucous membranes 9, 11.   
Development of dental plaque biofilm: Stages 
          The growth and development of Dental plaque biofilm involves 4 phases: initial 
attachment phase, lag phase, rapid growth phase and steady state phase 11.  
Phase 1 and 2: Initial attachment and Lag phase:   
          The first phase involved in the dental plaque biofilm formation is the formation of 
the pellicle which is a thin layer of salivary proteins that includes albumin, glycoproteins, 
acidic protein-rich proteins, mucins, cell debris, and exo products such as amylase, 
lysozyme and sialic acid 9, 10.  This pellicle coating forms on the tooth surface providing a 
sticky base on which colonization of specific bacteria occurs through specific interactions 
between bacterial surface components and salivary constituents 11.  The components of 
salivary pellicle including statherin, a salivary acidic phosphoprotein and proline-rich 
proteins promote the colonization of bacteria on to the tooth surfaces 12.  The early plaque 
forming bacteria or the initial colonizers are generally the gram positive cocci 11.  A 
phenotypic change occurs in the bacteria due to a shift of bacteria from planktonic life to a 
sessile life 11.  This needs a significant genetic up-regulation 11. A lag in the bacterial growth 
occurs once the genetic expression shifts 11. 
Phase 3: Rapid growth phase: 
          During this phase biofilm matrix is formed from the secretions of the adherent 
bacteria. These secretions constitute large volumes of water-insoluble extracellular 
polysaccharides 11.  The bacterial microcolonies grow in this extracellular polymeric matrix 
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11.  Furthermore these early colonizing bacterial micro colonies get attached to various 
other new free floating bacteria and this results in both auto aggregation and co-aggregation 
9.   This increases the bacterial complexity of the dental plaque biofilm 11.  Mutual support 
and competition among a highly diversified community of microorganisms occurs during 
the coaggregation of bacteria 13.  The process of coaggregation involves unique specific 
molecular interactions resulting in structural stratification within the biofilm 10.  The 
thickness of the biofilm increases as both coaggregation and cell division among the 
bacterial microflora progress 14-16. 
Phase 4: Detachment phase or Steady state: 
          During this phase disrupted bacterial cells and bacterial cells devoid of cytoplasm 
can be seen in the deeper layers of the biofilm while intact bacterial cells can be observed 
at the surface of the biofilms 11.  During this phase the interbacterial matrix might also 
exhibit crystals which may signify initial calculus mineralization 17.  In addition during this 
phase some of the bacteria detach from the biofilm surface sometimes as a reaction to 
harmful environmental conditions in relation to the bacteria 11.  These detached bacteria 
spread and colonize new surfaces in the oral cavity 11. 
          The initially colonizing bacteria predominantly consists streptococcus species which 
are gram positive facultative cocci.  In addition, the primary colonizers also constitute some 
gram positive rods and filaments and a few aerobic gram negative cocci 9, 10.  The growth 
and development of the microbial biofilm is based on the cell division of the attached 
bacteria 9.  Further these bacteria form mushroom shaped bacterial microcolonies attached 
to the tooth surface 9.  Most of the oral bacterial microflora are characterized by multiple 
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adhesion types on their cell surfaces which facilitate interactions with both the host surface 
molecules and other bacteria18.  
          Previous studies have shown that the healthy status of oral cavity is characterized by 
the predominant presence of gram positive cocci, some gram positive rods and filaments, 
few gram negative rods and a few gram negative cocci.  The healthy status of the oral cavity 
changes to diseased status as the gram positive cocci and gram positive rods are replaced 
predominantly by pathogenic gram negative anaerobes or acidophiles9.  After the plaque is 
predominantly composed of pathogenic bacteria, it results in the inflammation and swelling 
of the gingival margin which in turn results in deepening of the gingival sulcus 9. The supra 
gingival plaque extends into the deepened gingival sulcus and gradually forms sub-gingival 
plaque biofilm which is mainly composed of gram negative anaerobic bacteria 9. 
          Studies conducted by Socransky et. al 19 have observed 5 consistent complexes of 
bacterial species of which the red complex containing  Tanerella forsythus, 
Porphyromonas gingivalis and Treponema denticola has been significantly associated with 
clinical measures of periodontal disease, specifically pocket depth and bleeding on probing 
19. Adult periodontitis is associated with sub-gingival plaque and is characterized by the 
predominant presence of P. gingivalis 19.  Porphyromonas gingivalis is found in the 
samples of dental plaque as early as within 6 hours after oral prophylaxis 20, 21.  Oral 
prophylaxis is the complete removal of calculus, debris, stain and plaque and is performed 
by a trained specialist.  P. gingivalis were found in greater amount in the areas affected 
with periodontitis 22.  The association of P. gingivalis with the initial, early, middle and 
late colonizers during biofilm growth may explain the presence of P. gingivalis as early as 
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within 6hours after oral prophylaxis as well as its association with periodontal disease 
which is relatively a late event 23.   
          Previous studies have shown that the colonization of P. gingivalis depends on 
various factors such as a “preformed streptococcal substratum” 23, reduced oxygen tension 
and sufficient nutritional resources for it to get integrated into a biofilm 24, 25-27.  Though 
streptococcal species constitute about 60-90% of the initial colonizers on the tooth surface, 
P. gingivalis does not exhibit biofilm formation with all the streptococcal species 23. In fact 
P. gingivalis was observed to have “partner specificity23.” For example P. gingivalis did 
not show biofilm formation with Streptococcus oralis 28, Streptococcus mutans 13 and 
Streptococcus cristatus 29 whereas it effectively formed biofilms with S. gordonii 13 and 
formed biofilms with S. oralis only in the presence of S. gordonii in a three species 
community 23.  It did not readily form biofilms with S. mutans as there is a sequence 
variability between the antigens I/II proteins of S. mutans and S. gordonii which accounted 
for the binding selectivity of P. gingivalis 30.  In addition P. gingivalis did not exhibit co-
aggregation with some varieties of oral bacterial microflora like antinomies, 
aggregatibacteria, capnocytophagae, streptococcus 28 whereas it exhibited co-aggregation 
with Fusobacterium nucleatum (23, 28, 31). “P. gingivalis is capable of being an integral 
component of mutualistic multispecies oral biofilm communities at all stages of dental 
plaque development. 21”  
Significance of Porphyromonas gingivalis and Fusobacterium nucleatum 
interaction in biofilm formation: 
          Fusobacterium nucleatum also plays an important role in dental plaque biofilm 
formation due to its ability to colonize both with gram positive and gram negative bacteria 
in the oral cavity 32.  In fact F. nucleatum is also considered to be “microbial bridge” due 
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to its co-aggregation ability 33. It is found in high frequency in periodontal lesions 57.  
Fusobacterium nucleatum adheres to the early colonizers including Gram positive cocci 
and then later facilitates the co-aggregation with strong periodontal pathogenic bacteria 
like P. gingivalis 33.  
           Research studies showed that biofilm formation by F. nucleatum was significantly 
increased by the presence of P. gingivalis 34.  Both P. gingivalis and F. nucleatum were 
detected in the lesion areas associated with periodontitis 35.   
          The synergistic effect between P. gingivalis and F. nucleatum was comparatively the 
strongest when compared to other oral bacterial micro flora 34.  Studies on murine models 
have also shown a synergistic effect in relation to virulence between both the bacteria 36. 
Previous studies have shown that P. gingivalis co-aggregated with F. nucleatum in both in 
vivo and invitro 36.  These studies also examined the ability of P. gingivalis and F. 
nucleatum in inducing experimental periodontitis in mice 36.  They infected mice orally 
with P. gingivalis and F. nucleatum alone and as a mixed infection 36. No significant bone 
loss has been observed in mice infected only with either P. gingivalis or F. nucleatum alone 
which was similar to non- infected group of mice 36.  But the group of mice which were 
infected with a mixed infection of both P. gingivalis and F. nucleatum exhibited a 
significant alveolar bone loss compared to the sham-infected control group of mice and the 
group of mice which were infected with either only P. gingivalis or F. nucleatum alone 36. 
Though the same concentration of bacteria are used in mixed infection and mono-infection 
experiments the reason for significant alveolar bone loss in mixed infection group of mice 
might be because of the synergism in virulence between P. gingivalis and F. nucleatum 36.  
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Significance of Porphyromonas gingivalis and Streptococcus gordonii interaction in 
Dental plaque biofilm formation - Important facts and observations from previous 
research studies: 
           Previous studies showed that P. gingivalis adheres to S. gordonii through the 
interaction of the minor fimbrial antigen Mfa1 with a specific region of SspB polypeptide 
(residues 1167-1193) designated BAR 37. 
          SspB polypeptide is a ‘multi-functional polypeptide” which is 1500 residues in 
length and is the chief cell surface protein belonging to the antigen I/II family 38.  These 
studies also showed that an interaction between SspB polypeptide and a mucin like salivary 
glyco protein in a calcium-dependent reaction is crucial for the adherence of Streptococcus 
gordonii cells with the oral mucosal surface 38.  
            P. gingivalis interaction with F. nucleatum is facilitated by a galactose specific 
lectin 39 whereas its interaction with S. gordonii is “multimodal”.  The binding mechanism 
between P. gingivalis and S. gordonii involves the major fimbrial Fim A protein which 
extends 3µm from the cell surface and the species specific interaction between minor 
fimbrial Mfa1 protein and the streptococcal SspB polypeptide 13.”  The minor fimbrial 
antigen Mfa1 protein extends only 0.1-0.5µm from the cell surface 40, 41.  Though both the 
P. gingivalis major fimbrial Fim A protein and minor fimbrial Mfa1 protein interact with 
S. gordonii, the interaction of minor fimbrial Mfa1 protein with a specific region of the 
streptococcal SspB polypeptide is much more significant when compared to major fimbrial 
Fim A protein which binds with isogenic Ssp null mutant of S. gordonii DL1 42. This is 
because the Mfa1- SspB interaction is crucial for the induction of P. gingivalis biofilms on 
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streptococcal substrate whereas the interaction between P. gingivalis major fimbrial Fim 
A and isogenic Ssp null mutant of S. gordonii was unable to support biofilm growth 42. 
           A synthetic peptide was designed based on the BAR sequence which is a specific 
region of the streptococcal SspB polypeptide (residues 1167 to 1193) 37.  This specific 
region of streptococcal SspB polypeptide is known to interact with the minor fimbrial 
antigen Mfa1 of P. gingivalis thus facilitating the adherence of gram negative anaerobic 
organism- P. gingivalis with the gram positive aerobic cocci- S. gordonii 37,38.  Our 
previous invitro research studies showed that the synthetic BAR peptide potently inhibited 
the P. gingivalis Mfa1- S. gordonii SspB polypeptide interaction and also effectively 
reduced the depth of P. gingivalis micro-colonies formed in its presence37.  
         The specific inhibitory activity of BAR is influenced by several factors which when 
regulated might result in comparatively higher inhibitory activity of BAR. P. gingivalis 
expresses Lys-gingipains which might degrade the lysine residues present in the BAR37.  
In order to produce BAR peptides with more potent inhibitory activity, the L-amino acids 
in the BAR were replaced by D-amino acids and the direction of the BAR peptide backbone 
was reversed thus resulting in a BAR peptide which was designated as RI BAR37.  But RI 
BAR proved to be ineffective not only at concentrations 1-10µg/ml but even at higher 
concentrations of 50µg/ml37.  This indicates that only the native BAR but not its 
retroinverso analog can assume the functional conformation of SspB polypeptide that is 
recognized by the P. gingivalis minor fimbrial Mfa1 protein37.  These studies also involved 
development of conformationally constrained analog of BAR – CR BAR which had the 
same chirality of BAR but leucine residues at positions 1177 and 1191 were replaced with 
cysteine residues37.  This resulted in cyclic disulfide bonds which limited the bond rotations 
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within the peptide back bone of the NITVK sequence37.  CR-BAR did not exhibit any 
significant inhibition at 10µg/ml concentration whereas significant reduction in P. 
gingivalis micro colony formation on streptococcal substrate was observed at 50µg/ml of 
concentration37.  Furthermore experiments were conducted involving the functional 
screening of combinatorial libraries of BAR.  This included the replacement of active site 
residues (Asn1182, Thr1184, and Val1185) with each of the 19 common aminoacids37.  
The structural information obtained from these experiments that might be useful for further 
studies was 
i. Replacement of Asparginine at position 1182 with positively charged amino 
acids and substitution of Valine at position 1185 with hydrophobic residues 
promotes the adherence of P. gingivalis to the BAR peptide37. 
ii.  Substitution of the same amino acids with Proline or glycine was detrimental 
to the adherence of P. gingivalis to the BAR peptide37. 
iii. The effect of substitutions at Threonine was less prominent either positively or 
negatively compared to the other positions. This indicated that electrostatic 
forces and hydrophobic interactions contributed to Mfa1-SspB interaction37. 
 
          Using structural information obtained from the previous studies a BAR peptide was 
developed by substituting Asparginine at position 1182 with Arginine and Valine at 
position 1185 with Isoleucine which was designated BAR II. This BAR peptide analog 
when tested exhibited higher inhibitory activity of P. gingivalis Mfa1- streptococcal SspB 
interaction when compared to BAR peptide43.  Further studies were conducted to determine 
the importance of secondary structure of BAR as a part of which the predicted secondary 
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structures of the BAR peptide and BAR II were compared43.  The presence of Arginine and 
Isoleucine facilitated stabilization of the secondary structure of BAR in BAR II which 
resulted in a significantly greater α- helical content and less β sheet and random coil in 
solution43.  In order to determine if the BAR- mediated inhibition of P. gingivalis 
interaction with SspB polypeptide is connected to α- helical content, the conformationally 
constrained analog CR BAR which was developed in the previous studies is examined43.    
This study showed that CR BAR also contained 28% α helical content which suggested 
that the inhibitory activity is either independent of the secondary structure or substitution 
of leucine residues with cysteine residues to produce CR BAR disrupted the secondary 
structural motif important for the P. gingivalis- BAR interaction43.  To determine this 
further studies were conducted aiming on the region that were changed to generate CR 
BAR36.  These studies showed that substitution of leucine residues with cysteine residues 
to produce CR BAR disrupted the secondary structural motif important for the P. 
gingivalis- BAR interaction43.  This is because one of the leucine residues that was 
substituted with cysteine residue at position 1177 was part of a predicted amphipathic α 
helix that was similar to a known protein- protein interaction domain, the NR Box43.          
Previous studies have already shown that the NITVK motif is responsible for the P. 
gingivalis selective adherence to oral streptococci 37.  Further studies conducted to 
determine if the VXXLL region contributes to the interaction of BAR with P. gingivalis 
showed that both the motifs NITVK and VQDLL are required for the interaction of P. 
gingivalis with BAR43.  In addition the structural characteristics and the sequence of the 
VXXLL motif in BAR was consistent with the consensus NR BOX43. Incorporation of 
amino acids possessing the properties to disrupt the secondary structure of VXXLL 
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resulted in a reduction in the specific inhibitory activity of BAR which indicates that the 
putative α-helical character of VXXLL is essential for the Mfa1- BAR interaction43.  
          The VXXLL motif is also flanked by Lys residues at the -1, -2, +6 and +7 positions, 
and the substitution of acidic amino acids at these positions led to reduced inhibitory 
activity43. This suggested that the BAR-Mfa1 interaction may also be stabilized by a charge 
clamp comprising the flanking Lys residues43.  Furthermore the specificity of the 
coactivator-NR interaction is led by amino acids that are present either upstream or 
downstream from the core LXXLL motif 44.  The VXXLL motif in BAR is present 
immediately upstream from NITVK, which is responsible for the specificity of P. 
gingivalis adherence to the oralis group of streptococci 44. 
          In total these results suggest that P. gingivalis- streptococci interaction is facilitated 
by a protein-protein interacting domain of SspB (antigen I/II) that resembles the eukaryotic 
NR box domain43.  These studies suggest that the modification of the VXXLL and NITVK 
motifs, either to restrict the flexibility of the peptide or to maintain its α-helical character, 
might result in BAR peptide analogs with higher specific inhibitory activity43.  Together 
these studies suggested that the specific region of the SspB cell surface protein of 
streptococcal antigen I/II comprises of two motifs – KKVQDLLKK and NITVK motifs 
and that both the motifs have to be considered in developing potent structurally modified 
BAR peptide analogs that target the P. gingivalis adherence onto streptococcal substrate 
and subsequent biofilm formation43 .
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CHAPTER – 2 
HYPOTHESIS AND AIMS 
          The colonization of Porphyromonas gingivalis is the key phase in the transformation 
of the bacterial biofilm from a commensal plaque to the pathogenic form observed in 
periodontitis.  As mentioned in the previous chapter, previous studies have shown that P. 
gingivalis adheres to S. gordonii through the interaction of the minor fimbrial antigen Mfa1 
with a discrete region of the SspB polypeptide (residues 1167 to 1193) which is designated 
BAR 37.  Our previous studies have also shown that a synthetic peptide comprising the 
BAR sequence potently inhibits the interaction between P. gingivalis and S. gordonii and 
thus inhibiting the P. gingivalis biofilm formation 37.   
          Assessment of the efficiency of the BAR peptide and it’s analogs in inhibiting the P. 
gingivalis and S. gordonii interaction in a dual species biofilm and also in a more complex 
three species biofilm having F. nucleatum as the third species gives us valuable information 
to progress in the path to produce potent therapeutic compounds that might prevent or limit 
periodontal disease.  F. nucleatum was chosen as the third species for a more complex three 
species biofilm culture system as it  is considered to be a microbial bridge that co-
aggregates with not just  “oxygen-tolerant and other obligatory anaerobic species but 




Statement of Objectives and Hypothesis: 
          The goals of this study are to establish optimum levels of P. gingivalis, S. gordonii 
and F. nucleatum to reproducibly generate dual and three species complex biofilms and to 
examine inhibition of their formation by BAR peptide and its analogs (1) C1-24 R1182 I1185 
BAR, (2) R1182 I1185 BAR and (3) C1-24. 
 
Research Hypothesis: 
          Our hypothesis is that the structural information obtained from BAR peptide can be 
used to develop more potent inhibitors that target both simple and complex P. 
gingivalis biofilms and that preventing the S. gordonii- P. gingivalis interaction may 
influence the formation of more complex biofilms 
 
Specific Aims: 
          The Specific aims of the study were as follows: 
1. For simple dual species bio-film the aim is to establish optimum levels of S. 
gordonii and P. gingivalis in order to readily produce dual species biofilm and to 
test the efficiency of the structurally modified BAR peptides (1) C1-24 R1182 I1185 
BAR, (2) R1182 I1185 BAR and (3) C1-24 in more potently inhibiting P. gingivalis - S. 
gordonii dual species biofilm formation relative to parent BAR peptide. 
2. For three species complex biofilm the aim is to establish experimental conditions 
and optimum levels of S. gordonii, P. gingivalis and F. nucleatum to reproducibly 
generate three species complex biofilm and to test the efficiency of parent BAR and 
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it’s analogs (1) C1-24 R1182 I1185 BAR, (2) R1182 I1185 BAR and (3) C1-24 in inhibition 
of P. gingivalis and S. gordonii interaction in a three species complex biofilm and 
to determine if blocking S. gordonii- P. gingivalis interaction alters the formation 


















MATERIALS AND METHODS 
Dual species biofilm: 
          Porphyromonas gingivalis ATCC 33277 is a strain which is extensively used 
throughout many periodontal research studies.  Therefore it was grown anaerobically in 
pre- reduced Trypticase Soy broth media (TSBY media) (Difco) supplemented with 0.5% 
yeast extract, hemin and menadione without shaking for 48 hours at 37°C.  For this 
purpose, a ten milliliter sample of the TSBY media was pre- reduced under anaerobic 
conditions for 24 hours by equilibration in an atmosphere consisting of 10% CO2, 10% H2, 
and 80% N2.  
           Alternatively P. gingivalis was cultured using fresh Trypticase soy broth media 
blood agar plates which were pre- reduced and streaked using frozen stocks of P. gingivalis 
ATCC 33277.  P. gingivalis grown by either of the above mentioned methods was sub-
cultured into twenty milliliters of fresh pre-reduced TSBY media supplemented with yeast, 
hemin and menadione.  It was grown anaerobically for 48hours without shaking at 37°C. 
          Streptococcus gordonii DL-1 was cultured aerobically in ten milliliter samples of 
Brain heart infusion broth supplemented with 1% yeast extract (BHIY) without shaking 
O/N. For inoculation of S. gordonii, frozen stocks of Streptococcus gordonii DL- 1 strain 
were used. Alternatively Streptococcus gordonii DL- 1 was cultured using fresh Brain heart 
infusion media blood agar plates which were streaked using the frozen stocks of S. gordonii 
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DL- 1. S. gordonii grown by either of the above mentioned methods was sub-cultured into 
twenty five milliliter of BHIY and grown aerobically- O/N, without shaking. 
          After sub-culturing Streptococcus gordonii, a 1.5ml aliquot was dispersed into a 2ml 
eppendorf tubes a centrifuged at 5600 RPM for 5minutes.  The supernatant was discarded 
and the cell pellet was re- suspended in 1ml of 1X Phosphate buffer saline (1X PBS).  S. 
gordonii was labeled with 3µl-5µl of 10mM Hexidium iodide (5mg/ml, Molecular probes) 
for every 3ml of S. gordonii culture used.  After the S. gordonii cells were labeled – cells 
were incubated for 15 minutes at room temperature on a rocker platform protected from 
light.  Throughout the procedure the cells were protected from light by working in dim 
light and covering the samples with aluminum foil.  Following this incubation, the labeled 
cells were centrifuged at 5600 RPM for 5minutes, and the supernatant was discarded and 
the cells were re-suspended in 1ml of 1 X PBS.  The optical density (O.D) at 600nm of the 
cells was checked at 1:10 dilution of S. gordonii cells. 
          For establishing the optimum inocula for S. gordonii cells, biofilms were formed 
using S. gordonii at different optical densities including 0.1, 0.2, 0.5 and 0.8 and the 
optimal conditions were found to use an optical density of 0.8 for S. gordonii.  Formation 
of a uniform confluent layer of S. gordonii was taken as criteria for the selection of 
optimum optical density. 
          All the subsequent experiments were carried out using the optimal conditions 
identified above.  The optical density of S. gordonii was adjusted to 0.8 using 1X PBS.A 
12 well culture plate (cell treat cell culture plate) - was taken with 1 each of a sterilized 
micro cover slip added to each well.  1ml each of the labeled Streptococcus gordonii cells 
with optical density 0.8 was added into each appropriate well in the 12 well culture plate. 
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The 12 well cell culture plate was covered with aluminum foil in order to protect the labeled 
cells from light and then placed on a rocker platform on the lowest possible rocker setting 
in the anaerobic chamber at 37°C and incubated for 18- 24 hours.  On the same day 
autoclaved 1X PBS was pre-reduced in the anaerobic chamber to be used for the following 
procedure. 
           The amount of P. gingivalis used for biofilm culture was optimized using a similar 
approach.  P. gingivalis cells sub- cultured and grown under anaerobic conditions were 
taken and 1.5 ml aliquots was dispersed into a 2ml eppendorf tubes and centrifuged for 
5min at 5600 RPM.  Pre-reduced 1XPBS was used throughout the procedure.  The 
supernatant was discarded and cell pellet was re-suspended into 1ml of pre-reduced 1X 
PBS.  P. gingivalis cells were labeled with 1µl- 3µl of 5-(6) carboxyfluorescein – 
succinylester (4mg/ml, Molecular probes) for every 3ml of P. gingivalis culture used.  
After the P. gingivalis cells were labeled – cells were incubated for 30 minutes at room 
temperature on a rocker platform protected from light.  Throughout the procedure the cells 
were protected from light by working in a dim light and covering the samples with 
aluminum foil.  Following the incubation the labelled cells were centrifuged at 10000 RPM 
for 1minute and the supernatant was discarded and the cells were re-suspended in 1ml of 
pre- reduced 1 X PBS.  The optical density (O.D) at 600nm of the cells was checked at a 
1:10 dilution of P. gingivalis cells. 
          For establishing the optimum inocula for P. gingivalis cells, various experiments 
were done using dual species biofilms which were formed using P. gingivalis cells at 
various optical densities that include 0.05,0.1,0.2,0.5 and0.8.  The optimal conditions were 
found to use an optical density of 0.1 for P. gingivalis cells.  A uniform distribution of 
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distinct micro colonies of P. gingivalis adhering to the streptococcal substratum was taken 
as the criteria for choosing the ideal conditions. 
          All the subsequent experiments were carried out using the optimal conditions 
identified above.  The optical density was adjusted to 0.1 using 1XPBS. 
          For the control biofilm the sample at this stage was added 1ml each into each well 
of the 12 well cell culture plate after the removal of the supernatant from the previous 
day. 
          For biofilm inhibition experiments, BAR peptide and BAR peptide analogs were 
pre-incubated with labeled P. gingivalis cells at concentrations of 0 to 10 µg per ml at 25°C 
for 30 min before adding to the appropriate wells.  The 12 well cell culture plate was 
covered with aluminum foil and incubated for 18-24 hours in the anaerobic chamber similar 
to previous day.  1X PBS was pre-reduced for the next step in the procedure. 
          Following 18- 24 hours of incubation the supernatant was removed from the wells 
of the 12 well cell culture plate and the cells were washed with 1ml of pre-reduced 1XPBS 
to remove any non- adherent bacterial cells.  Following the wash 4% paraformaldehyde 
solution was added 1ml each to each well.  This solution serves to fix the cells. After 
5minutes the paraformaldehyde solution was removed and the cells were washed with pre- 
reduced 1X phosphate buffer saline.  Following this procedure, the cover slip was mounted 
on to a slide glass using Prolong gold anti-fade reagent. 
          Under these conditions, the streptococci formed a confluent layer on the micro 
coverslip. P. gingivalis subsequently formed distinct micro colonies on the streptococci 
which were quantified by confocal microscopy as described below. 
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Confocal Laser scanning Microscopy: 
          P. gingivalis-S. gordonii biofilms were visualized and imaged using an Olympus 
Fluoview 500 confocal laser scanning microscope (Olympus, Pittsburgh, PA). Confocal 
laser scanning microscopy was chosen for imaging because of its high-resolution optical 
images with depth selectivity.  It produces blur-free images of thick specimens at various 
depths 45.  It acquires in-focus images at selected depths and this process is known as optical 
sectioning. Images are taken point-by-point and reassembled with a computer, rather than 
projected through an eyepiece which facilitates the three dimensional imaging and 
reconstruction of topologically complex objects45. CLSM is widely used in 
numerous biological science disciplines.  
          The slides were viewed under the confocal laser scanning microscopy and z stack 
images were formed.  All the slides were viewed using a 60× objective lens using an argon 
laser for visualization of FITC labeling and the HeNe-G laser to visualize hexidium iodide-
labeled streptococci.  The number and height of FITC-labeled P. gingivalis microcolonies 
were determined from 30 to 60 randomly chosen frames using the FluoView software 
package provided by Olympus.  Microcolony depth was determined by performing z-plane 
scans from 0 µm to 30 µm above the cover glass surface.  P. gingivalis micro colonies that 
formed on S. gordonii in the absence of inhibitor ranged from 4 to 19 µm in depth under 
the experimental conditions used.  We used an image resolution of 1024×1024.  We used 
a Fast scan speed as slow scan speeds also increase the amount of time required to capture 
an image and may increase the risk of photo toxicity.  Background noise- if any present 
was removed using the volocity software during image processing.  The Z-step size used 
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was 0.7µm. Image acquisition of z-stacks of optical slices of the biofilms was done and 
images were analyzed using volocity software. 
Image Analysis: 
          After the images were captured by confocal laser scanning microscopy the resulting 
optical slices were digitally processed and reconstructed in 3D using Volocity software.  
3D data analysis in z-stacks of optical slices could overcome the majority of classification 
errors associated with x and y, but requires advanced software and high volume data 
management. Volocity is one of several commercially available advanced high 
performance 3D-4D image analysis software packages that can measure all volumetric 
pixels (i.e. voxels in total volume of z-stacks of optical sections) and therefore gain better 
signal overlap detection in all x, y and z axes improving compiling of cell structures as well 
as fate classification. 
          Images were imported into Volocity as multiple tiff- file format. The software 
supports several other image acquisition platform file formats.  A uniform filter was used 
to remove noise from the system and measurements were performed to identify cells.  The 
image brightness and contrast enhancement options were used for high quality images and 
a snapshot of image was captured which was used to measure the volume of the bacteria.  
In the process of analyzing as this was dual species biofilm we selected two channel and 
assigned respective fluorescent dyes with which the bacteria were labeled and then the 
images were analyzed with the following basic settings: i. Restrict Analysis to – All 
populations, ii. Summarized by – Sum, iii. Row- Population.  The obtained data was 
exported and saved and the images were exported as snapshot and saved in Jpeg format. 
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          This is a highly helpful tool using which we analyzed data for measuring the 
effectiveness of BAR peptides and its analogs in inhibiting the S. gordonii and P. gingivalis 
experiments. 
Data Analysis: 
          Once the values in relation to population or volume of each bacteria were obtained, 
the mean and Standard deviation of S. gordonii values and P. gingivalis values were 
measured and the average volume of P. gingivalis per average volume of S. gordonii was 
determined. This indicates the volume of P. gingivalis present per a given amount S. 
gordonii.  
          Based on these values, the percentage of inhibitory activity of the BAR peptide and 
the peptide analogs 1. C1-24 R1182I1185 BAR, 2. R1182 I1185 BAR and 3. C1-24 BAR at 
concentrations 1µg/ml, 5µg/ml and 10µg/ml was determined.  To determine if the rate of 
inhibition of BAR peptide analogs was statistically significant compared to BAR peptide 
two tailed t-tests with significance level 5% (α=0.05) were performed with significance 
level on the data sets using Microsoft Excel Analysis Toolpak. 
Synthesis of peptides and combinatorial peptide libraries. 
           The peptides that were used in this study are shown in Fig. 1 as shown in pg. 25. 
The BAR peptide (Fig. 1A.) and its analogs (Fig. 1B, 1C, 1D.) were synthesized by 
Biosynthesis, Inc. (Lewisville, TX).  All peptides were obtained at greater than 90% purity.  
The BAR peptide comprises amino acids 1167 to 1193 of the S. gordonii SspB polypeptide 
(Fig 1A.). 
          Three structurally modified BAR peptide analogs which were synthesized using the 
structural information from the BAR peptide were chosen for our research studies.  
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They are as follows: 
1. C1-24 R1182 I1185 BAR 
2. R1182 I1185 BAR and 
3. C1-24 BAR 
          C1-24 R1182 I1185 BAR peptide was synthesized by replacing the leucine residues at 
positions 1167 and 1191 with cysteine.  This resulted in a cyclic disulfide bond that limited 
bond rotations within the peptide backbone of the intervening active site NITVK 
sequence30.  In addition, asparginine is replaced by arginine at position 1182 and valine at 
position 1185 is replaced by isoleucine.  Arginine (R) is a positively charged amino acid 
and isoleucine is a hydrophobic residue.  Previous studies showed a BAR peptide analog 
CR BAR whose leucine residues at positions 1177 and 1191 when substituted by cysteine 
residues exhibited poor inhibitory activity 37.  This was due to the fact that leucine residue 
at position 1177 is a part of a motif, VXXLL that resembles a known protein –protein 
interacting domain, the NR box found in coactivators of NRs of eukaryotes 43.  Substitution 
of this leucine residue at position 1177 with cysteine caused disruption of the second 
important region of the BAR that is required for P. gingivalis adhesion43. 
           Therefore in developing the current BAR peptide analog only the leucine residues 
at position 1167 and 1191 are substituted with cysteine molecules preventing the disruption 






 (A). LEAAPKKVQDLLKKANITVKGAFQLFS 
 
 (B). CEAAPKKVQDLLKKARITIKGAFQCFS 
      
 (C).  
 
 (D). CEAAPKKVQDLLKKANITVKGAFQCFS 









FIG. 1. (A) Sequence of BAR peptide used in this study. BAR peptide is comprised 
of amino acid residues 1167 to 1193 of the S. gordonii SspB protein. The underlined 
sequence, NITVK, represents active site residues involved in the adherence of P. 
gingivalis to SspB and BAR with Asn at position 1182 and Val at position 1185. 
(B). Sequence of BAR peptide analog C1-24R1182I1185 BAR. The leucine residues at 
positions 1167 and 1191 were replaced with cysteine and Asn at position 1182 is 
replaced by Arginine and Valine at position 1185 replaced with Isoleucine.  
(C). Sequence of BAR peptide analog R1182I1185 BAR. Asn at position 1182 is 
replaced by Arginine, Valine at position 1185 replaced with Isoleucine. Leucine 
residues remain unchanged  
(D). Sequence of BAR peptide analog C1-24 BAR. The leucine residues at positions 
1167 and 1191 of the BAR peptide were replaced with cysteine. Asn and Val at 
positions 1182 and 1185 remain unchanged. 
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          R1182 I1185 BAR was synthesized by substituting Asn at position 1182 with positively 
charged amino acid Arg and substituting Val at position 1185 with hydrophobic amino acid 
Ile which were shown to promote P. gingivalis adherence to BAR.  In this BAR peptide 
analog the leucine residues were not substituted with cysteine.  The peptide sequence of 
this BAR peptide analog is as shown in Fig. 1C. 
          C1-24 BAR was synthesized by substituting the leucine residues at positions 1167 and 
1191 with cysteine thus resulting in a cyclic disulfide bond that limits the bond rotation 
within the peptide backbone of the intervening active site NITVK sequence.  Asn at 1182 
position and Val at position 1185 were not replaced.  The peptide sequence of this BAR 
peptide analog is as shown in Fig. 1D. 
Three species biofilm: 
          Fusobacterium nucleatum was chosen for three species biofilm experiments because 
of its ability to adhere to both gram positive and gram negative plaque forming micro-
organisms and previous studies demonstrated its ability to co-aggregate with suspected 
periodontal pathogens. 
          P. gingivalis and S. gordonii were grown as previously described for the dual species 
biofilm cultures.  F. nucleatum was grown anaerobically in pre- reduced Brain heart 
infusion media (BHI media) (Difco) supplemented with hemin and menadione without 
shaking for 96 hours at 37°C.  For this purpose, a twenty five milliliter sample of the TSBY 
media was pre- reduced under anaerobic conditions for 24 hours by equilibration in an 
atmosphere consisting of 10% CO2, 10% H2, and 80% N2. Pre-reduced medium was 
inoculated using frozen stocks of F. nucleatum.  Alternatively F. nucleatum grown using 
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fresh Brain heart infusion media (BHI) blood agar plates which were pre- reduced and 
streaked using frozen stocks of F. nucleatum may be used instead of the frozen stocks for 
inoculation.  
 
          The first step in three species biofilm was addition and incubation of S. gordonii 
cultures in the 12well cell culture plate as described in the dual species biofilm.  The same 
day F. nucleatum cultures grown anaerobically for 72- 96 hours without shaking were 
removed from the anaerobic chamber and centrifuged for 20minutes at 3000RPM.  The 
supernatant was discarded and the cell pellet formed was re-suspended in 1ml of 1X PBS.  
DDAO-SE (Molecular probes) which is a fixable far red fluorescent tracer was chosen to 
label F. nucleatum cells.  The optical density (O.D) at 600nm of the cells was checked at a 
1:10 dilution of F. nucleatum cells. 
         For establishing the optimum inocula for F. nucleatum cells, three species biofilms 
were formed using F. nucleatum cells at various optical densities that include 0.1,0.2,0.5 
and1.0 and 2.0.  A uniformly distributed attachment of F. nucleatum cells to both S. 
gordonii and P. gingivalis forming thick complex biofilms was observed at an optical 
density of 2.0 which was chosen for our experiments.  All subsequent experiments were 
carried out using the optimal conditions identified above. 
          F. nucleatum samples at O.D 2.0 were labeled with 2mM DDAO-SE.  The amount 
of DDAO-SE was calculated based on two factors as follows: 




2. The volume of F. nucleatum cells taken from the 1ml F. nucleatum solution formed 
by re-suspending the pellet in 1ml 1X PBS as described earlier. 
          The labeled F. nucleatum cells were protected from light with aluminum foil and 
placed on the rocker platform separately along with the 12 well cell culture plate with S. 
gordonii cells.  The rocker platform is maintained at the lowest possible rocker setting. 1X 
PBS were pre- reduced for the next step. 
          For establishing the optimum inocula for Porphyromonas gingivalis for the three 
species complex biofilm, three species biofilms were formed with P. gingivalis cells at 
various optical densities that include 0.1, 0.2, 0.5 and 1.0.  The optimal conditions were 
found to use an optical density of 0.2 for P. gingivalis cells based on uniform distribution 
and distinct microcolony formation on streptococcal substrate. 
          Following an incubation period of 18- 24 hours of S. gordonii cells, the supernatant 
from the previous day was removed before the labeled P. gingivalis cells and labeled F. 
nucleatum cells were added simultaneously to each necessary well.  This forms the three 
species biofilm on the micro coverslip which acts as a control in the experiments.  
          The P. gingivalis control sample and samples with BAR peptide or its analogs were 
prepared as described in dual species biofilms with an exception that the optical density for 
P. gingivalis used here is 0.2 for the formation of complex biofilm.  The F. nucleatum 
sample of optical density 2.0 is prepared from the labeled cells and pre-reduced 1X PBS. 
Following this, the samples were added at 1ml each simultaneously into the respective 
wells of the 12 well cell culture plate after the supernatant from the previous day was 
removed. Throughout the procedure the labeled cells were protected from light. Pre-
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reduced 1X PBS was used throughout the procedure as necessary.  After the samples were 
added, the 12 well cell culture plate is covered with an aluminum foil and was placed on a 
rocker platform with the lowest possible rocker setting.  Incubation time is 18-24 hours. 
After 18- 24 hours of incubation the 12 well cell culture plate is removed from the 
anaerobic chamber.  The procedure for fixing and mounting of the micro coverslip onto the 
slide glass is as described in dual species biofilms. 
 
The three species complex biofilms were viewed under confocal laser scanning 
microscopy. DDAO SE is excited by the far red 633nm laser.  The dyes that were assigned 
to the three species while imaging are FITC to P. gingivalis, TEXAS RED to S. gordonii 
and CY5 to F. nucleatum.  All the settings on confocal laser scanning microscope were as 
described in dual species biofilm.  Images formed were saved and analyzed using volocity 
software. Analyzing a three species biofilm on volocity software is similar to dual species 
biofilm with an exception that in three species biofilm we select three channel setting and 
assign CY5 for the third bacterium along with FitC and Texas Red. 
After the data was obtained, the average S. gordonii values, average P. gingivalis values, 
average F. nucleatum values were calculated after normalizing the average S. gordonii 
values.  Based on these values, the percentage of inhibitory activity of the BAR peptide 
and peptide analogs 1. C1-24R1182I1185 BAR, 2. R1182I1185 BAR, 3. C1-24 BAR at 
concentrations 10µg/ml, 25µg/ml and 50µg/ml were determined. 






                              
                                                                   
                                                                                                                                                                               
                                                       
                                                                
                                                                                   
                             











+ BAR PEPTIDE 
Step 3 
Step 4 
FIG. 2. Step 1- S. gordonii cells were labeled with Hexidium iodide and added to 
micro coverslips in 12 well cell culture plate followed by incubation under anaerobic 
conditions. Step 2- P. gingivalis cells labeled with carboxyfluorescein 5, 6- succinyl 
ester incubated with the respective BAR peptide and F. nucleatum cells labeled with 
DDAO- SE added to the micro coverslips after removal of supernatant followed by 
incubation under anaerobic conditions. Step 3- Micro coverslips are fixed and 
mounted onto slides and visualized under Olympus Fluoview FV500 Laser Scanning 
Microscopy. Step4- Optical slices formed under CLSM are reconstructed into 3D 
images using volocity software. 











BAR peptide and its analogs inhibit formation of P. gingivalis dual and three species 
complex biofilms.  
          Our previous invitro studies have shown that a synthetic peptide comprising the BAR 
sequence potently inhibited the P. gingivalis Mfa1 – S. gordonii SspB interaction thus 
preventing P. gingivalis biofilm formation 37.  Subsequently functional screening of 
combinatorial libraries involving the replacement of three amino acids (Asn1182, Thr1184, 
and Val1185) within active site NITVK region of BAR with each of the 19 common amino 
acids showed that positively charged amino acids at position 1182 and hydrophobic 
residues at position 1185 bound to P. gingivalis more efficiently when compared to the 
control peptide containing Asn and Val at these positions respectively 37.  Aspartate and 
proline were detrimental to P. gingivalis adherence at all three positions, and replacement 
of glycine at residues 1182 and 1184 reduced P. gingivalis adherence 37. 
           The BAR peptide constitutes amino acid residues 1167 to 1193 of the S. gordonii 
SspB cell surface protein as shown in Fig. 1A. The amino acid residues which promoted 
P. gingivalis adherence to the BAR peptide and those which were detrimental to P. 
gingivalis adherence to the BAR peptide are shown in Fig. 3
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          Further studies conducted to produce more potent inhibitors of P. gingivalis- S. 
gordonii Mfa1- SspB interaction have shown that along with NITVK motif a secondary 
structural motif VQDLL whose structural characteristics are consistent in consensus with 
the NR BOX was found to be essential for the Mfa1- BAR interaction 43. The VQDLL is 
predicted to be a hydrophobic α-helix43.  Disrupting the secondary structure of VXXLL 
resulted in a decreased specific inhibitory activity of BAR suggesting that the putative α 
helical character is essential for the P. gingivalis Mfa1 interaction with the streptococcal 
SspB polypeptide43.  Together these studies have shown that both the motifs KKVQDLLK 
and NITVK should be taken into account 43 along with the other structural information 
obtained from the BAR peptide in the previous research studies, in developing structurally 
modified BAR peptide analogs that might act as potent inhibitors of P. gingivalis Mfa1- S. 
gordonii SspB interaction and biofilm formation. 
           To determine if the structural information obtained from the BAR peptide from 
previous studies could be exploited to produce more potent inhibitors of P. gingivalis 
biofilm formation, three structurally modified BAR peptide analogs were designed using 
the structural information from the BAR peptide as described in the previous chapter. 
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Detrimental        D,E         D    D 
to P. gingivalis       P          P     P 
                adherence           G          G 
Figure 3. Screening of combinatorial libraries of BAR involved 
replacement of three active site residues Asn1182, Thr1184, and Val1185 
with each of the 19 common amino acids 37. This study conducted by 
Daep et. al resulted in peptide mixtures where position 1182 when 
substituted with positively charged aminoacids and when position 
1185 was replaced by hydro-phobic amino acids as shown - it 
promoted P. gingivalis adherence to the BAR peptide37. In contrast 
Aspartic acid or proline at all the three positions were detrimental to 
P. gingivalis adherence 37. Glycine at positions 1182 and 1184 was 
also detrimental to P. gingivalis adherence to BAR peptide37. 
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Dual Species Biofilm 
          Our initial experiments were focused on establishing optimum inocula for P. 
gingivalis and S. gordonii to reproducibly generate  dual species biofilms for testing the 
inhibitory activity of BAR peptide analogs when compared to the BAR peptide.  To 
accomplish this we conducted various experiments using S. gordonii and P. gingivalis at 
various optical densities.  S. gordonii was tested at optical densities that include 0.1, 0.2, 
0.5, 0.8 and P. gingivalis was tested at optical densities that include 0.05, 0.1, 0.2 and 0.5 
as shown in Fig. 4. (A-J).  The optimal conditions were found to use an optical density of 
0.8 for S. gordonii and 0.1 for P. gingivalis to reproducibly generate dual species biofilms.  
At an optical density of 0.8, S. gordonii formed a confluent uniform layer as shown in Fig. 
4.B which was considered to be ideal for our experiments.  At an optical density of 0.1, P. 
gingivalis was found to have a uniform distribution with distinct micro colony formation 
adhering to the streptococcal substrate as shown in Fig. 4.H which was considered as ideal 




            
 
    
 
             
 
    
   









                                              
 
    













Fig. 4. Dual species community of S. gordonii and P. gingivalis at different 
optical densities 
Confocal laser scanning analysis of heterotypic communities of S. gordonii (red) 
and P. gingivalis (green). 
 (A). S. gordonii at O.D 0.5.  (B). S. gordonii at O.D 0.8. (C). S. gordonii at O.D 0.5 
and P. gingivalis at O.D 0.2. (D). S. gordonii at O.D 0.5 and P. gingivalis at O.D 
0.1.  (E). S. gordonii at O.D 0.5 and P. gingivalis at O.D 0.05 (F). S. gordonii at 
O.D 0.5 and P. gingivalis at O.D 0.02 (G). S. gordonii at O.D 0.8 and P. gingivalis 
at O.D 0.05.  (H). S. gordonii at O.D 0.8 and P. gingivalis at O.D 0.1.  (I). S. gordonii 
at O.D 0.8 and P. gingivalis at O.D 0.5. (J). S. gordonii at O.D 0.8 and P. gingivalis 





          Once the optimal conditions were established, the dual species biofilms were tested 
with the BAR peptide and the peptide analogs 1.C1-24 R1182 I1185 BAR, 2. R1182 I1185 BAR 
and 3.C1-24 BAR at concentrations of 1µg/ml, 5µg/ml and 10µg/ml as described in the 
previous chapter.  Previous studies showed that BAR peptide significantly inhibited P. 
gingivalis biofilm formation at a concentration of 10µg/ml.  So we chose the concentrations 
of 1µg/ml, 5µg/ml and 10µg/ml to determine if the structurally modified BAR peptide 
analogs showed potent inhibition compared to BAR peptide at a concentration of either 
10µg/ml or lesser. 
           Initially the BAR peptide  was tested at concentrations 1µg/ml, 5µg/ml and 10µg/ml 
and it’s inhibitory activity was compared with control biofilm which was formed using S. 
gordonii cells at an optical density of 0.8 and P. gingivalis cells with an optical density of 
0.1.  The population of the individual bacteria were measured by the volocity software from 
the images formed by the confocal laser scanning microscopy.  The BAR peptide inhibited 
the P. gingivalis micro colonies development on the S. gordonii substratum effectively at 
a concentration of 10µg/ml as shown in Table1. 
          Subsequently the BAR peptide analogs 1. C1-24 R1182 I1185 BAR, 2. R1182 I1185 BAR 
and 3. C1-24 BAR and the BAR peptide were tested at concentrations 1µg/ml, 5µg/ml and 
10µg/ml. The inhibitory activity of the peptide analogs was directly compared to the 








          Pre-incubation of P. gingivalis with 1 µg/ml of BAR peptide did not show much 
inhibition of P. gingivalis micro colonies.  It exhibited only 4% of inhibition of P. 
gingivalis microcolonies.  At 5µg/ml BAR peptide showed 20% of inhibition of P. 
gingivalis microcolonies.  Though BAR peptide did not exhibit significant inhibition at 
1µg/ml and 5µg/ml concentrations, at 10µg per ml BAR peptide showed 77% of inhibition 
suggesting that the peptide competitively inhibited the P. gingivalis microcolony formation 
on S. gordonii substratum.   Thus, a soluble synthetic 27-mer peptide representing the 
adherence-promoting region of SspB effectively competes with the intact 170-kDa 
streptococcal cell surface protein for the P. gingivalis short fimbrial protein Mfa1 37.  
The rate of inhibition by the BAR peptide on P. gingivalis adherence to S. gordonii is 





    



















S-g-P.g Control Parent Bar Peptide C1-24 R1182 I1185
BAR
R1182 I1185 BAR C1-24 BAR
*
Fig. 5. Effectiveness of BAR peptide and BAR peptide analogs at 10µg/ml on 
Streptococcus gordonii and Porphyromonas gingivalis dual species biofilm 
formation 
Dose response of BAR peptide and its analogs C1-24R1182I1185 BAR, R1182I1185 BAR, 
C1-24 BAR at 10µg/ml concentration. The data acquired was analyzed and statistical 
difference in the rate of inhibition of P. gingivalis- S. gordonii interaction by BAR 
peptide and its analogs was determined by Anova followed by post-hoc t-tests using 
Microsoft excel Analysis Toolpak. When the rate of inhibition of P. gingivalis- S. 
gordonii interaction by BAR peptide analogs was compared with BAR peptide, the 






    
Control 
1µg/ml 5µg/ml 10µg/ml 
Parent BAR 0% 4% 20% 77% 
C1-24 R1182 
I1185 BAR 
0% 6% 27% 70% 
R1182I1185 
BAR 
0% 44% 62% 87% 
C1-24 BAR 0% 22% 42% 77% 
TABLE 1. Dose Response of BAR Peptide and its Analogs in P. gingivalis- S. 

















Average or Mean of  
P.g / S.g Volume         
± Standard Deviation 
Percentage of 
Inhibition 
Control 0.3 ± 0.1 0% 
Parent BAR 10µg/ml 0.07 ± 0.01 77% 
C1-24 R1182 I1185 BAR 
10µg/ml 
0.09 ± 0.01 70% 
R1182 I1185 BAR 
10µg/ml 
0.04 ± 0.008 87% 
C1-24 BAR 10µg/ml 0.07 ± 0.008 77% 
TABLE 2. Percentage of inhibition of P. gingivalis- S. gordonii interaction by 
BAR peptide and its analogs at 10µg/ml 
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          The BAR peptide analogs were also tested at 1µg/ml, 5µg/ml and 10µg/ml 
concentrations. BAR peptide and its analogs showed significant inhibition at 10µg/ml 
concentration as shown in Table 1. and Table 2. 
 
C1-24R1182I1185 BAR: 
           As described in Materials and methods the C1-24R1182I1185 BAR has cysteine 
molecules at positions 1167 and 1191 which forms a cyclic di-sulfide bond that aids in 
limiting bond rotations within the peptide backbone of the intervening active site NITVK 
sequence 37.  Arginine is a positively charged amino acid and Isoleucine is hydrophobic.  
Previous research studies have shown that peptides containing positively charged amino 
acids at position 1182 or hydrophobic residues at position 1185 bound P. gingivalis more 
effectively than did control peptides containing Asn and Val at these positions, suggesting 
that electrostatic and hydrophobic interactions may contribute to Mfa1-SspB binding 37. 
 
          C1-24R1182I1185 BAR did not show much inhibition at 1µg/ml concentration. It 
exhibited only 6% inhibition at this concentration (Fig. 7B.).   At 5µg/ml it exhibited 27% 
inhibition (Fig. 7C.) of P. gingivalis adherence to S. gordonii.  Though at 1µg/ml and 
5µg/ml concentration significant inhibition wasn’t observed by C1-24R1182I1185 BAR, it 
exhibited 70% inhibition of P. gingivalis adherence on streptococcal substratum (Fig. 7D.) 


























Fig. 6. Inhibition of P. gingivalis- S. gordonii dual species biofilm formation by 
BAR peptide analogs at 1µg/ml, 5µg/ml, at 10µg/ml. The percentage of inhibition 
of P. gingivalis microcolony formation on S. gordonii substratum is calculated. 
The BAR peptide analogs C1-24R1182I1185  BAR at 10µg/ml concentration, R1182I1185 
BAR at 5µg/ml and 10µg/ml concentration and C1-24 BAR at 5µg/ml and 10µg/ml 




    
                       
   
   
            
C D 
Fig. 7. Effectiveness of C1-24R1182I1185 BAR in inhibition of P. gingivalis- S. 
gordonii interaction       (A). S. gordonii – P. gingivalis dual species biofilm control. 
(B). Inhibition of P. gingivalis- S. gordonii interaction by C1-24R1182I1185 BAR at 
1µg/ml. (C). Inhibition of P. gingivalis- S. gordonii interaction by C1-24R1182I1185 
BAR at 5µg/ml (D) Inhibition of P. gingivalis- S. gordonii interaction by C1-
24R1182I1185 BAR at 10µg/ml concentration. 

















CONTROL-S.G P.G C1-24 R1182 I1185 BAR
1µg/ml





Fig. 7 (E). Dose response of C1-24 R1182 I1185 BAR in inhibition of P. gingivalis 
microcolony formation on S. gordonii substrate. It showed a statistically significant 





          This peptide analog has positively charged amino acid arginine at 1182 position and 
hydrophobic residue Isoleucine at 1185 position.  The leucine molecules at positions 1167 
and 1191 remain unchanged as in BAR peptide. This BAR peptide analog showed 
competitive inhibition of P. gingivalis micro colonies on S. gordonii at 10µg/ml 
concentration when compared to the inhibition by BAR peptide at 10µg/ml as shown in 
Table1.  
          R1182I1185 BAR showed 44% inhibition at 1µg/ml concentration (Fig. 8B) and 62% 
inhibition of the P. gingivalis adherence to S. gordonii at 5µg/ml concentration (Fig. 8C). 
At 10µg/ml concentration it showed 87% of inhibition of P. gingivalis micro colonies on 
S. gordonii substratum as shown in (Fig 8D.) and Table1.  





             
   
              
              
   
              





R1182 I1185 BAR 
Fig. 8. Effectiveness of R1182I1185 BAR in inhibition of P. gingivalis- S. gordonii 
interaction.  (A). S. gordonii – P. gingivalis dual species biofilm control.                   
(B). Inhibition of P. gingivalis- S. gordonii interaction by R1182I1185 BAR at 1µg/ml. 
(C). Inhibition of P. gingivalis- S. gordonii interaction by R1182I1185 BAR at 5µg/ml 





























Fig. 8. (E). Dose response of R1182 I1185 BAR in inhibition of P. gingivalis microcolony 
formation on S. gordonii substrate. It showed a statistically significant inhibition   (p< 





          This peptide analog consists of cysteine molecules at positions 1167 and 1191 which 
form cyclic di-sulfide bond that limits bond rotation within peptide backbone.  It contains 
Asparginine at position 1182 and Valine at position 1185 as in BAR peptide. 
C1-24 BAR showed 22% inhibition at 1µg/ml concentration (Fig 9B) and 42% inhibition 
rate at 5µg/ml (Fig. 9C.) concentration.  It exhibited 77% of inhibition at 10µg/ml (Fig. 
9D.) concentration as shown in Table1.  The dose response of C1-24 BAR is as shown in 
Fig. 9E  
 
          At a concentration of 10µg/ml the inhibitory activity of the BAR peptide and its 
analogs C1-24 R1182 I1185 BAR, R1182 I1185 BAR and C1-24 BAR was significant compared to 
the control (Fig. 5. And Fig. 6).  In specific the inhibitory activity of R1182 I1185 BAR was 
statistically greater when compared to the BAR peptide and the other structurally modified 
BAR peptides- C1-24 R1182 I1185 BAR and C1-24 BAR.  Its rate of inhibition of the P. 
gingivalis – S. gordonii interaction was much higher when compared to the BAR peptide 
at 10µg/ml concentration and therefore R1182 I1185 BAR is a more potent inhibitor of  the P. 
gingivalis- S. gordonii dual species biofilm formation compared to BAR peptide. 





   
 
                              
  
 






Fig. 9. Effectiveness of C1-24 BAR in inhibition of P. gingivalis- S. gordonii 
interaction 
(A). S. gordonii – P. gingivalis dual species biofilm control.                                             
(B). Inhibition of P. gingivalis- S. gordonii interaction by C1-24 BAR at 1µg/ml.     
(C). Inhibition of P. gingivalis- S. gordonii interaction by C1-24 BAR at 5µg/ml       
















CONTROL-S.G P.G C1-24, 1µG/ML C1-24, 5µG/ML C1-24,10µg/ml
*
Fig. 9. (E). Dose response of C1-24 BAR in inhibition of P. gingivalis microcolony 
formation on S. gordonii substrate. It showed a statistically significant inhibition   
(p<0.001) at 5µg/ml and 10µg/ml concentration when compared to the control. 
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Three Species biofilm: 
          Once the efficiency of the structurally modified BAR peptides in inhibiting the P. 
gingivalis- S. gordonii dual species biofilm formation was established, we then tested the 
efficiency of the BAR peptide and the structurally modified BAR peptides C1-24 R1182 I1185 
BAR, R1182 I1185 BAR and C1-24 BAR in a multi species biofilm which was a three species 
complex biofilm.  P. gingivalis, S. gordonii and F. nucleatum were the three species that 
were used in the complex biofilm formation. 
          Our initial experiments were focused on establishing optimum inocula for P. 
gingivalis, S. gordonii and F. nucleatum to reproducibly generate three species complex 
biofilms for testing the inhibitory activity of BAR peptide and BAR peptide analogs.  To 
achieve this, three species biofilms were formed at different optical densities and 
compared.  The optimum conditions were found to use an optical density of 0.8 for 
Streptococcus gordonii, 0.2 for P. gingivalis and 2.0 for Fusobacterium nucleatum. S. 
gordonii formed a uniform confluent layer at optical density 0.8. P. gingivalis showed a 
uniform distribution and distinct micro colony formation at an optical density of 0.2 on S. 
gordonii. F. nucleatum at an optical density of 2.0 formed thick complex biofilms with S. 
gordonii and P. gingivalis. 
 Streptococcus gordonii was labeled with hexidium iodide, Porphyromonas gingivalis was 
labeled with 5- (6) Carboxy fluorescein - succinyl ester and Fusobacterium nucleatum was 
labeled with DDAO-SE. Texas RED, FITC and CY5 were the fluorescent dyes assigned  
to the labeled bacterial cells while imaging using confocal laser scanning microscopy. 
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          Once the optical densities were established, three species biofilms were formed and 
the BAR peptide was tested at concentrations 1µg/ml, 5µg/ml, 10µg/ml, 25µg/ml and 
50µg/ml. The inhibitory activity was compared with S. gordonii, P. gingivalis and F. 
nucleatum three species biofilm control.  At 1µg/ml, 5µg/ml and 10µg/ml – BAR peptide 
did not exhibit any significant inhibitory activity in relation to the three species biofilm.  
Though BAR peptide and its analogs did not show significant inhibition at 1µg/ml and 
5µg/ml concentration they showed competitive inhibition at 10µg/ml in dual species 
biofilms.  This indicates that BAR peptide and its analogs were not as effective as in Dual 
species biofilm at 10µg/ml concentration in a three species complex biofilm. 
          So therefore we tested the BAR peptide and the three peptide analogs- 1. C1-24 
R1182 I1185 BAR, 2. R1182 I1185 BAR and 3. C1-24 BAR at 10µg/ml, 25µg/ml and 50µg/ml 
concentrations.  The inhibitory activity was compared directly to the three species biofilm 
control.  The population of each individual bacteria are measured by the Volocity software 
based on the fluorescent dyes they were labeled with from the images that were formed 
using confocal laser scanning microscopy. 
          An interesting observation that was seen in these experiments was that there was a 
reduction in F. nucleatum values as the P. gingivalis Mfa1- S. gordonii SspB interaction 
was inhibited by the BAR peptide and the BAR peptide analogs.  This might be due to the 








          Pre-incubation of P. gingivalis with 10 µg/ml of BAR peptide did not show much 
inhibition of P. gingivalis microcolonies (TABLE 3).  It exhibited only 10.1% of inhibition 
of P. gingivalis microcolonies at 10µg/ml (Fig. 10. B). At 25µg/ml BAR peptide showed 
28% of inhibition of P. gingivalis microcolonies. Though BAR peptide did not exhibit 
significant inhibition at 10µg/ml and 25µg/ml concentrations, at 50µg per ml BAR peptide 
showed 84.1% of inhibition (Fig. 10. C) suggesting that the peptide competitively inhibited 
the P. gingivalis microcolony formation on S. gordonii substratum at 50µg/ml 
concentration. The rate of inhibition by the BAR peptide on P. gingivalis adherence to S. 
gordonii in a three species complex biofilm is shown in TABLE 3. 
          At a concentration of 10µg/ml there was no reduction observed in F. nucleatum 
volume (Fig. 10B). At a concentration of 25µg/ml of BAR peptide when P. gingivalis was 
reduced by 28% there was a 34% reduction in F. nucleatum volume. At 50µg/ml 
concentration of BAR peptide when P. gingivalis was reduced by 84.1% there was a 78% 
reduction that was observed in F. nucleatum (Fig. 10C).  
The dose response of BAR peptide and its analogs on P. gingivalis adherence to S. gordonii 
are shown in Table 3 and percentage reduction in F. nucleatum volume due to the effect 
from the inhibition of P. gingivalis-S. gordonii interaction by the BAR peptide and its 
analogs is shown in Table4. 
          The BAR peptide analogs were also tested at 10µg/ml, 25µg/ml and 50µg/ml 
concentrations. BAR peptide and its analogs showed significant inhibition at 50µg/ml 




    
          
       
                          
 





Fig. 10. Three species community of S. gordonii, P. gingivalis and F. nucleatum. 
Confocal laser scanning analysis of heterotypic communities of S. gordonii (red), P. 
gingivalis (green) and F. nucleatum (blue). Effectiveness of BAR peptide in 
inhibition of P. gingivalis- S. gordonii interaction in a three species biofilm.  (A). S. 
gordonii – P. gingivalis three species biofilm control. (B). Inhibition of P. gingivalis- 
S. gordonii interaction by BAR Peptide at 10µg/ml. (C). Inhibition of P. gingivalis- 
S. gordonii interaction by BAR Peptide at 50µg/ml in a three species biofilm. 
 
 
(A). S. gordonii, P. gingivalis and F. nucleatum three species biofilm control. Fig. 
10(B) and 10(C) Inhibition of P. gingivalis- S. gordonii interaction in a three species 






          C1-24R1182I1185 BAR did not show inhibition of P. gingivalis at 10µg/ml concentration 
(Fig. 11. B). At 25µg/ml it exhibited 40% inhibition (Fig. 11. C) of P. gingivalis adherence 
to S. gordonii.  Though at 25µg/ml concentration significant inhibition wasn’t observed by 
C1-24R1182I1185 BAR, it exhibited 87.5% inhibition of P. gingivalis adherence on 
streptococcal substratum at 50µg/ml concentration (Fig. 11. D). 
          At 10µg/ml concentration of C1-24R1182I1185 BAR when P. gingivalis showed no 
reduction, there was no reduction observed even in F. nucleatum volume (Fig. 11. B). At 
25µg/ml concentration of C1-24R1182I1185 BAR when P. gingivalis showed 40% inhibition 
(Fig. 11. C), there was a 59% reduction observed even in F. nucleatum volume and at 
50µg/ml concentration (Fig. 11. D) of C1-24R1182I1185 BAR when there was an 87.5% 















                                       
 
     
   













Fig. 11. Effectiveness of C1-24R1182I1185 BAR in inhibition of P. gingivalis- S. gordonii 
interaction in a three species biofilm.   
(A). S. gordonii – P. gingivalis three species biofilm control. (B). Inhibition of P. 
gingivalis- S. gordonii interaction by C1-24R1182I1185 BAR at 10µg/ml. (C). Inhibition 
of P. gingivalis- S. gordonii interaction by C1-24R1182I1185 BAR at 25µg/ml (D). 
Inhibition of P. gingivalis- S. gordonii interaction by C1-24R1182I1185 BAR at 50µg/ml 
concentration. 
 






          This peptide analog has positively charged amino acid arginine at 1182 position and 
hydrophobic residue Isoleucine at 1185 position.  R1182I1185 BAR showed 68% inhibition 
at 10µg/ml concentration (Fig. 12B) and 72.3% inhibition of the P. gingivalis adherence to 
S. gordonii at 25µg/ml concentration (Fig. 12C).  At 50µg/ml concentration it showed 88% 
of inhibition of P. gingivalis microcolonies on S. gordonii substratum as shown in (Fig 
12D). 
 
          At 10µg/ml concentration of R1182I1185 BAR when P. gingivalis showed 68% 
reduction, there was 1.5% reduction observed in F. nucleatum volume (Fig. 12B).  At 
25µg/ml concentration of R1182I1185 BAR when P. gingivalis showed 72.3% inhibition, 
there was a 63.5% reduction observed in F. nucleatum volume (Fig. 12C) and at 50µg/ml 
concentration of C1-24R1182I1185 BAR when there was an 88% inhibition of P. gingivalis, a 









                                                  
                                                      
        
  




Fig. 12. Effectiveness of R1182I1185 BAR in inhibition of P. gingivalis- S. gordonii 
interaction in a three species biofilm.   
(A). S. gordonii – P. gingivalis three species biofilm control.                                                     
(B). Inhibition of P. gingivalis- S. gordonii interaction by R1182I1185 BAR at 10µg/ml.   
(C). Inhibition of P. gingivalis- S. gordonii interaction by R1182I1185 BAR at 25µg/ml              
(D). Inhibition of P. gingivalis- S. gordonii interaction by R1182I1185 BAR at 50µg/ml 
concentration. 
 





           C1-24 BAR showed reduction in S. gordonii along with reduction in P. gingivalis and 
F. nucleatum as shown in figure.  Because of the reduction in S. gordonii when P. gingivalis 
and F. nucleatum average volumes were calculated after normalizing average S. gordonii 
value to the average volume of the S. gordonii control to determine the percentage of 
inhibition, it did not give any reduction in the P. gingivalis and F. nucleatum values.  The 
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Fig. 13.  Effectiveness of C1-24 BAR in inhibition of P. gingivalis- S. gordonii interaction 
in a three species biofilm.   
(A). S. gordonii – P. gingivalis three species biofilm control.                                                   
(B). Inhibition of P. gingivalis- S. gordonii interaction by C1-24 BAR at 10µg/ml.           
(C). Inhibition of P. gingivalis- S. gordonii interaction by C1-24 BAR at 25µg/ml           
(D). Inhibition of P. gingivalis- S. gordonii interaction by C1-24 BAR at 50µg/ml 
concentration in a three species biofilm. 
 





















Parent  BAR 0% 10.1% 28% 84.1% 







0% 68% 72.3% 88% 












TABLE 3. Percent Inhibition of P. gingivalis microcolony formation on S. 







      











Parent BAR 0% No reduction 
  
 34% reduction 78% reduction 
C 1-24 R1182 I1185 
BAR 
0% No reduction 59% 88.5% 
R1182 I1185  BAR 0% 1.5% 63.5% 85.1% 
C 1-24  BAR 0%  Reduction in S. 
gordonii volume 
also observed. 
Reduction in S. 
gordonii volume 
also observed. 
Reduction in S. 
gordonii volume 
also observed. 
TABLE 4. Percentage of reduction in F. nucleatum levels due to the inhibition of P. 




          The three species biofilm that was formed was much more complex when 
compared to dual species biofilm.  Thick biofilms were observed in the three species 
biofilm.  To determine if synergism between P. gingivalis and F. nucleatum was the 
reason for the complexity of the three species biofilm and the reason for reduction in F. 
nucleatum volume as P. gingivalis microcolonies were inhibited by the BAR peptide and 
its analogs, we formed S. gordonii and F. nucleatum biofilms as shown in Fig. 14. (A-B) 
and compared it with three species complex biofilm.   But they were similar to the dual 
species biofilm in appearance though the dual species biofilms were formed by S. 
gordonii and P. gingivalis.  This shows that there is a strong synergism between P. 
gingivalis and F. nucleatum which increased the complexity of the three species biofilm 
resulting in robust biofilms and in the absence of P. gingivalis the S. gordonii-F. 
nucleatum biofilm was not complex when compared to the three species biofilm.  This 
agrees with the previous research done involving P. gingivalis and F. nucleatum 
supporting the fact that P. gingivalis and F. nucleatum have a strong synergistic effect 46. 
          Though BAR peptide and its analogs potently inhibited three species biofilm at 
50µg/ml concentration, the structurally modified BAR peptide R1182 I1185 BAR showed a 
comparatively significant inhibition of the three species biofilm at all the three 
concentrations 10µg/ml, 25µg/ml and 50µg/ml when compared to BAR peptide, C1-24 R1182 









Figure. 14. (A) AND (B). Streptococcus gordonii (red- Hexidium iodide) - 








          The periodontal pathogen P. gingivalis is a highly proteolytic, asaccharolytic gram 
negative anaerobe 47. Its primary niche is the anaerobic environment of the sub- gingival 
dental plaque 37. But the early plaque formation and initial colonization starts at the supra 
gingival surfaces 37. In order to get established in the oral cavity, P. gingivalis has to survive 
the aerobic environment, should have sufficient nutritional sources and mainly it has to 
reach its primary niche where it can interact with other gram negative obligate and 
facultative anaerobes. To accomplish this P. gingivalis which is a secondary colonizer 
adheres to the primary colonizing bacteria at the supra-gingival surfaces. 
          Previous studies have shown that S. gordonii adheres to the periodontal pathogen P. 
gingivalis through the interaction of P. gingivalis minor fimbrial antigen Mfa1 with a 
specific region of the streptococcal SspB polypeptide(residues 1167 to 1193) designated 
BAR and that a synthetic peptide comprising the BAR sequence effectively inhibited the 
P. gingivalis – S. gordonii biofilms37.  This synthetic peptide is termed as BAR peptide. 
Further investigations done on the BAR peptide provided structural information that was 
used to design structurally modified BAR peptides.  Our current studies focused on testing 
the efficiency of these structurally modified BAR peptides in the inhibition of P. gingivalis-
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 S. gordonii in a dual species biofilm when compared to the BAR peptide.  Furthermore we 
also wanted to test the efficiency of the BAR peptide and its peptide analogs in inhibiting 
P. gingivalis-S. gordonii interaction in a three species complex biofilm and to determine if 
blocking the interaction alters the formation of three species biofilms.  
          Here we show that a BAR peptide analog R1182 I1185 BAR synthesized using 
structural information from BAR functioned as a potent inhibitor of P. gingivalis adherence 
to S. gordonii and its subsequent formation of biofilms when compared to BAR peptide. 
 
          From our results in dual species biofilms, we calculated that the number of P. 
gingivalis microcolonies that formed on the streptococcal substrate reduced by 87% in the 
presence of approximately 10µg of peptide inhibitor per ml.  This observation agrees with 
the previous research suggesting that electrostatic and hydrophobic interactions may 
contribute to Mfa1-SspB binding and that the SspB-Mfa1 interaction does not strictly 
depend on the specific amino acid occupying these positions in SspB but rather on the 
physical properties and characteristics of the amino acid residue.  Our results showed that 
the BAR peptide and its analogs significantly inhibited P. gingivalis microcolony 
formation on S. gordonii substrate at 10µg/ml in a dual species biofilm as shown in Fig. 5, 
Fig. 6, Table. 1 and Table. 2.  The dose response of R1182I1185 BAR at 10µg/ml 
concentration was statistically greater when compared to BAR peptide as shown in Fig. 5. 
The inhibitory activity of C1-24 R1182I1185 BAR was 7% less than the activity of BAR peptide 
at 10µg/ml and the inhibitory activity of C1-24 BAR was equal to BAR peptide at 10µg/ml 




          To determine if the BAR peptide and its analogs inhibit P. gingivalis and S. gordonii 
interaction in a three species complex biofilm and also to determine if blocking S. gordonii- 
P. gingivalis interaction alters the formation of 3 species biofilm we tested BAR peptide 
and its analogs in three species complex biofilms as described in Materials and Methods. 
 
          Our results showed that BAR peptide and its analogs showed effective inhibition at 
50µg/ml whereas the inhibition at 10µg/ml was minimal or negligible.  This suggests that 
BAR peptide and its analogs showed less specific inhibitory activity in a three species 
biofilm when compared to dual species biofilm.  This might be due to the fact that the 
complexity of three species biofilm was much higher compared to dual species biofilm.  
This may be because of the strong synergism present between P. gingivalis and F. 
nucleatum which increase the complexity of three species biofilm by several fold compared 
to dual species biofilm.  Previous studies have shown that P. gingivalis can form a 
heterotypic community with F. nucleatum and S. gordonii 48.  These studies have also 
shown that a community lifestyle facilitates physiologic support to P. gingivalis and that 
P. gingivalis increased in biomass due to attachment and recruitment 48.  Previous studies 
have shown a synergistic effect on pathogenicity between P. gingivalis and F. nucleatum 
invitro and in a murine model 46.   Coaggregation between F. nucleatum and P. gingivalis is 
strong and it may have the capability to alter the expression of virulence factors in 
individual microorganisms 46.   Previous studies have shown that P. gingivalis enhanced 
the growth of F. nucleatum thus presenting a direct evidence of P. gingivalis exerting a 
synergistic effect on biofilm formation by F. nucleatum 49.  Our results agree with the 
previous studies mentioned above that an increase in the biomass resulting in an increase 
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in complexity of the biofilm occurs when P. gingivalis and F. nucleatum coaggregate with 
each other. 
 
          Other interesting feature found in our experiments was that F. nucleatum also 
reduced as the P. gingivalis- S. gordonii interaction was inhibited in the three species 
biofilm.  So as the volume of P. gingivalis reduced- the synergistic effect is automatically 
reduced which in turn might have led to the reduction in the complexity of the three species 
biofilm.  These results suggest that P. gingivalis and F. nucleatum have strong synergism 
between them which agrees with the previous studies as mentioned above.  These results 
also emphasize on the fact that P. gingivalis might be the key pathogen involved in the 
transformation of a commensal plaque to pathogenic form.  This agrees with previous 
studies conducted on P. gingivalis in murine models 50.  
          Our results show that when P. gingivalis and S. gordonii interaction is inhibited 
either by BAR peptide or its analogs a significant reduction in both P. gingivalis and F. 
nucleatum was observed inspite of the strong co-aggregation and synergism present 
between them. Infact the reduction in P. gingivalis microcolonies formation on S. gordonii 
substratum led to the fall of the whole community suggesting that P. gingivalis might be 
the key pathogen in dental plaque.  
          The significance of this study is that we showed that BAR peptide and its analogs 
efficiently reduced P. gingivalis adherence to S. gordonii which interaction is v. important 
for its initial colonization in the oral cavity and to reach its primary niche.  This reduction 
of P. gingivalis either by BAR peptide or its analogs was observed even in the presence of 
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F. nucleatum suggesting that BAR peptide and its analogs might represent potential 
therapeutic compounds that may prevent or limit periodontitis. 
          In closing, future directions for experimental work include to synthesize easily 
reproducible compounds in low cost and less time having the same potent inhibitory 
properties as that of BAR peptide and its analogs.  To find the cause of reduction in S. 
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